Krka d. d (KRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Krka d. d (KRK) has a cash flow conversion efficiency ratio of 0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł130.67 Million ≈ $35.96 Million USD) by net assets (zł2.64 Billion ≈ $726.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KRK company net worth for the company's overall valuation and market capitalisation.
Krka d. d - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Krka d. d's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Krka d. d Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Krka d. d ranked by their cash flow conversion efficiency. Explore Krka d. d earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Aeroportuario del Pacífico S.A.B. de C.V
MX:GAPB
|
0.183x |
|
China Merchants Shekou Industrial Zone Holdings
SHE:001979
|
0.019x |
|
Guangzhou Tinci Materials Technology Co Ltd
SHE:002709
|
0.038x |
|
Empresas Copec S.A.
SN:COPEC
|
0.017x |
|
UNITED UTILITIES GP ADR/2
F:UUEA
|
N/A |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
N/A |
|
Orkla ASA
OL:ORK
|
0.023x |
|
Addtech AB (publ.)
ST:ADDT-B
|
0.106x |
Annual Cash Flow Conversion Efficiency for Krka d. d (2010–2025)
The table below shows the annual cash flow conversion efficiency of Krka d. d from 2010 to 2025. View Krka d. d (KRK) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł2.38 Billion ≈ $654.54 Million |
zł530.48 Million ≈ $146.00 Million |
0.223x | +38.29% |
| 2024-12-31 | zł2.24 Billion ≈ $615.87 Million |
zł360.93 Million ≈ $99.33 Million |
0.161x | +54.85% |
| 2023-12-31 | zł2.18 Billion ≈ $600.45 Million |
zł227.25 Million ≈ $62.54 Million |
0.104x | -52.37% |
| 2022-12-31 | zł2.14 Billion ≈ $588.55 Million |
zł467.65 Million ≈ $128.70 Million |
0.219x | +8.69% |
| 2021-12-31 | zł1.92 Billion ≈ $528.16 Million |
zł386.10 Million ≈ $106.26 Million |
0.201x | -2.30% |
| 2020-12-31 | zł1.75 Billion ≈ $482.12 Million |
zł360.76 Million ≈ $99.29 Million |
0.206x | -1.75% |
| 2019-12-31 | zł1.67 Billion ≈ $458.92 Million |
zł349.52 Million ≈ $96.19 Million |
0.210x | +11.35% |
| 2018-12-31 | zł1.54 Billion ≈ $423.90 Million |
zł289.95 Million ≈ $79.80 Million |
0.188x | +22.92% |
| 2017-12-31 | zł1.49 Billion ≈ $409.44 Million |
zł227.83 Million ≈ $62.70 Million |
0.153x | +3.61% |
| 2016-12-31 | zł1.44 Billion ≈ $397.53 Million |
zł213.49 Million ≈ $58.76 Million |
0.148x | -25.23% |
| 2015-12-31 | zł1.41 Billion ≈ $386.95 Million |
zł277.94 Million ≈ $76.49 Million |
0.198x | +56.41% |
| 2014-12-31 | zł1.35 Billion ≈ $372.06 Million |
zł170.87 Million ≈ $47.03 Million |
0.126x | -44.37% |
| 2013-12-31 | zł1.33 Billion ≈ $366.75 Million |
zł302.75 Million ≈ $83.32 Million |
0.227x | +1.26% |
| 2012-12-31 | zł1.24 Billion ≈ $341.41 Million |
zł278.33 Million ≈ $76.60 Million |
0.224x | +3.51% |
| 2011-12-31 | zł1.14 Billion ≈ $313.68 Million |
zł247.06 Million ≈ $67.99 Million |
0.217x | +25.79% |
| 2010-12-31 | zł1.05 Billion ≈ $289.89 Million |
zł181.52 Million ≈ $49.96 Million |
0.172x | -- |
About Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company offers prescription pharmaceuticals for cardiovascular, central nervous system, gastrointestinal tract, pain, diabetes, an… Read more